drugset
drugset / Trial / NCT00942708

Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension

NCT00942708 ↗

Phase 2 Completed 6 enrolled University of Texas Southwestern Medical Center National Center for Research Resources (NCRR) · collab
NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the safety, tolerability and efficacy of open-label fluoxetine for three months among patients with pulmonary arterial hypertension.

Timeline

Start
2009-09
Primary completion
2011-06
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluoxetine Small molecule 40 mg —

Indications

pulmonary arterial hypertension